WallStreetZenWallStreetZen

NYSE: DOCS
Doximity Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Doximity earnings were $223.2M for the trailing 12 months ending Mar 31, 2025, with 52.6% growth year over year. The latest DOCS earnings report on Mar 31, 2025 announced Q1 2025 earnings of $62.5M, down 16.9% from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, DOCS reported annual earnings of $223.2M, with 51.2% growth. The next DOCS earnings date is Aug 7, 2025.

DOCS past earnings growth

How has DOCS's earnings growth performed historically?

Company
52.56%
Industry
20.58%
Market
33.86%
DOCS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DOCS's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DOCS's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DOCS earnings history

Current Revenue
$570.4M
Current Earnings
$223.2M
Current Profit Margin
39.1%

DOCS Return on Equity

Current Company
22.4%
Current Industry
9.9%
Current Market
31.3%
DOCS's Return on Equity (22.4%)... subscribe to Premium to read more.
High Return on Equity Performance

DOCS undefined

Current Company
19.3%
Current Industry
5.2%
DOCS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DOCS announces earnings.

DOCS undefined

Current Company
23.79%
Current Industry
9.3%
DOCS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DOCS vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DOCS$276.07M$223.19M+49.38%$1.19
SOLV$1.29B$379.00M-70.78%$2.18
HQY$379.70M$121.81M+168.67%$1.40
WAY$329.58M$26.08MN/A$0.13
BTSG$468.92M$57.23MN/A$0.30
View Top Health Information Service Stocks

DOCS earnings dates

Next earnings date
Aug 7, 2025

Doximity Earnings Reports & History FAQ

What were Doximity's earnings last quarter?

Doximity (NYSE: DOCS) reported Q1 2025 earnings per share (EPS) of $0.33, up 50% year over year. Total DOCS earnings for the quarter were $62.46 million. In the same quarter last year, Doximity's earnings per share (EPS) was $0.22.

If you're new to stock investing, here's how to buy Doximity stock.

When does Doximity report earnings?

The next DOCS earnings call is Invalid Date. Add DOCS to your watchlist to be reminded of Doximity's next earnings date.

Is Doximity profitable or losing money?

As of the last Doximity earnings report, Doximity is currently profitable. Doximity's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $223.19 million, a 51.23% increase year over year.

What was DOCS's earnings growth in the past year?

As of Doximity's earnings date in Q3 2025, Doximity's earnings has grown 52.56% year over year. This is 31.98 percentage points higher than the US Health Information Services industry earnings growth rate of 20.58%. DOCS earnings in the past year totalled $223.19 million.

What are Doximity's earnings expectations?

The current EPS estimate for Doximity's earnings report in Invalid Date is $0.31.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.